Omnyk

The Problem

Omnyk faced a significant challenge in addressing the alarming global issue of cardiovascular diseases (CVDs), which account for approximately 31% of total deaths worldwide. In India alone, the situation was dire, with 2.7 million deaths in 2016, a number projected to rise substantially by 2030. The critical need to counter this menace, especially for the younger generation, prompted Omnyk to focus on reducing the high 30-day readmission rate of around 20%. Effective management during this phase was crucial, as it was estimated that timely care could save the lives of approximately 8% of patients facing this critical period.